Part the Cloud Awards $24M to Researchers Studying Potential Alzheimer’s Treatments

Mary Chapman avatar

by Mary Chapman |

Share this article:

Share article via email
Part the Cloud program

To help accelerate the development of treatments for Alzheimer’s disease, the Alzheimer’s Association’s Part the Cloud research grant program is investing $24 million in clinical trials investigating 16 potential therapies.

Scientists from around the world will use the funds to conduct Phase 1 and 2 trials testing a variety of experimental medications and devices.

The studies involve prospective treatments that focus on how brain cells use energy and fuel, and how they extract waste and debris from the brain. They also explore how blood supply in the brain is maintained.

“We must leave no stone unturned when it comes to finding treatments for Alzheimer’s and all other dementia, and Part the Cloud is designed to explore every feasible option in order to drive research forward to get potential treatment options to people living with Alzheimer’s faster,” Maria C. Carrillo, PhD, the Alzheimer’s Association chief science officer, said in a press release.

Led by philanthropist Mikey Hoag, the grant program supports early-stage clinical investigations with the goal of slowing, stopping, or impeding Alzheimer’s progression. Microsoft co-founder Bill Gates joined Part the Cloud last year with a $10 million award, which led to another $20 million in funding from the Alzheimer’s Association.

The program brings together government, academia, industry, and philanthropists to accelerate science and support researchers. Because dementia affects 50 million individuals globally, including 5 million in the U.S., there is an urgent need for more treatments.

“I couldn’t be more thrilled to see how Part the Cloud has grown. Thanks to philanthropic partners like Bill Gates, Part the Cloud is able to invest in more cutting-edge science, and fund researchers who are pushing science into new territories,” Hoag said. “Having seen both of my parents suffer from Alzheimer’s, it is my mission to help move this innovative research forward to find new answers.”

Among this year’s Part the Cloud grant recipients:

More information on the Part the Cloud program is available here.

Aduhelm Approved